Clinical Advisory & Governance
Senior clinical judgement, on tap
From audit and QI to guidelines, pilots and market access — clinically-led advisory that reduces risk and moves decisions forward.
Overview
Governance that enables, not blocks
Good clinical governance should make safe innovation faster, not slower. We provide the advisory, documentation and oversight that lets NHS teams, startups and providers move with confidence — and prove their decisions to boards and regulators.
Services
How we help
Audit & Quality Improvement →
Audit packs, QI storyboards and outcomes reporting that satisfy governance.
Guideline, Policy & SOP Development →
Change-controlled clinical documentation with stakeholder review.
Clinical & Case Review →
Specialist review within clear scope and confidentiality boundaries.
NHS Pilot Design & Evaluation →
Pilot charters, metrics and a credible path to scale.
Startup Clinical Advisory →
Fractional clinical leadership and founder office-hours.
Procurement & Market-Access Readiness →
Buyer packs and routes-to-market for bids and entry.
Engagement models
Flexible by stage and need
- Scoping callUnderstand the problem, governance context and decision you need to reach.
- Fixed first deliverableAn audit pack, SOP, pilot charter or governance review to prove value fast.
- Retained advisoryOngoing senior clinical input scaled to your roadmap.
Why it matters
Governance is the language procurement speaks
When an NHS trust, integrated care board or independent provider considers a new service, pathway or product, the decision rarely turns on the clinical idea alone. It turns on whether the supporting evidence is documented, whether risk has been assessed and owned, and whether the change can be defended to a board, a CQC inspector or a procurement panel. That is the gap our clinical advisory work closes. We translate a good clinical intention into the artefacts that let a busy decision-maker say yes with confidence — a clear audit, a ratified policy, a pilot with credible metrics, or a buyer-ready evidence pack.
Because our team is clinically led, the documentation we produce reflects how care is actually delivered rather than how a template assumes it should be. That distinction matters in front of clinicians, who quickly disengage from governance that feels disconnected from the ward, the clinic or the pathway. Whether you are formalising a quality-improvement programme, preparing for an inspection, or building the case for a new digital tool, the aim is the same: make the safe choice the easy choice to approve.
Working on a digital or AI-enabled product? Pair governance with independent AI Validation & Clinical Safety so clinical-risk management (DCB0129/DCB0160-style thinking) and intended-use boundaries are documented to the standard buyers expect.
Who we work with
Three groups, one need for defensible decisions
NHS & provider teams
Clinical and operational leads who need extra senior capacity to run an audit, refresh policies, or evaluate a pilot to a standard a board will accept.
Founders & scale-ups
Health-tech and device teams who need fractional clinical leadership and the governance evidence that unlocks NHS pilots and procurement. See Startup Clinical Advisory.
Bid & market-entry teams
Suppliers assembling capability statements and buyer packs ahead of a tender, supported by our Procurement & Market-Access Readiness work.
Each engagement begins by agreeing scope, confidentiality and the specific decision you need to reach, so effort goes only where it changes the outcome. Where a piece of work overlaps with evidence generation or service measurement, we connect it to our Healthcare Data & Analytics capability; where it needs a publishable write-up, we draw on Research & Scientific Writing. If the right answer is a named specialist rather than a retained relationship, we can source one through the Expert Network. To see what NHS buyers actually look for before they commit, read our NHS buyer-readiness guidance.
Answers
Frequently asked questions
What does a retained clinical advisory engagement look like?
A monthly retainer gives you ongoing access to senior clinical input — governance review, documentation, pilot oversight and decision support — scaled to your needs. Many clients start with a scoping call and a fixed first deliverable.
Can you support clinical governance for a digital health product?
Yes. We cover clinical risk management, intended-use boundaries, human oversight and the documentation procurement teams expect. This complements our AI Validation & Clinical Safety work.
Do you provide medico-legal opinions?
No. Our clinical and case review is advisory and bounded; it is not a medico-legal report and excludes regulated clinical decision-making. We set scope and confidentiality explicitly in every engagement.
Who typically signs off the documents you produce?
We draft to your governance structure so the final owner is clear — clinical lead, Caldicott Guardian, SIRO or board, depending on the document. Everything is change-controlled and version-tracked so an audit trail exists from first draft to ratified version.
How does this work fit alongside our existing governance team?
We supplement rather than replace. Most engagements give an internal team extra senior capacity for a defined piece of work — an audit, an SOP set, a pilot evaluation — while accountability stays with your organisation. See our Audit & Quality Improvement service for a typical starting point.
Book a scoping call
Tell us the decision you need to reach and we'll propose a first deliverable.